Literature DB >> 9261404

The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11.

P J Valk1, S Hol, Y Vankan, J N Ihle, D Askew, N A Jenkins, D J Gilbert, N G Copeland, N J de Both, B Löwenberg, R Delwel.   

Abstract

A new common region of virus integration, Evi11, has been identified in two retrovirally induced murine myeloid leukemia cell lines, NFS107 and NFS78. By interspecific backcross analysis, it was shown that Evi11 is located at the distal end of mouse chromosome 4, in a region that shows homology with human 1p36. The genes encoding the peripheral cannabinoid receptor (Cnr2) and alpha-L-fucosidase (Fuca1) were identified near the integration site by using a novel exon trapping system. Cnr2 is suggested to be the target gene for viral interference in Evi11, since proviruses are integrated in the first intron of Cnr2 and retroviral integrations alter mRNA expression of Cnr2 in NFS107 and NFS78. In addition, proviral integrations were demonstrated within the 3' untranslated region of Cnr2 in five independent newly derived CasBrM-MuLV (mouse murine leukemia virus) tumors, CSL13, CSL14, CSL16, CSL27, and CSL97. The Cnr2 gene encodes a seven-transmembrane G-protein-coupled receptor which is normally expressed in hematopoietic tissues. Our data suggest that the peripheral cannabinoid receptor gene might be involved in leukemogenesis as a result of aberrant expression of Cnr2 due to retroviral integration in Evi11.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261404      PMCID: PMC191960     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Structure and sequence of the human alpha-L-fucosidase gene and pseudogene.

Authors:  K A Kretz; D Cripe; G S Carson; H Fukushima; J S O'Brien
Journal:  Genomics       Date:  1992-02       Impact factor: 5.736

Review 2.  Retroviral insertional mutagenesis as a strategy to identify cancer genes.

Authors:  J Jonkers; A Berns
Journal:  Biochim Biophys Acta       Date:  1996-05-16

3.  G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity.

Authors:  L F Allen; R J Lefkowitz; M G Caron; S Cotecchia
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

4.  His-1 and His-2: identification and chromosomal mapping of two commonly rearranged sites of viral integration in a myeloid leukemia.

Authors:  D S Askew; C Bartholomew; A M Buchberg; M B Valentine; N A Jenkins; N G Copeland; J N Ihle
Journal:  Oncogene       Date:  1991-11       Impact factor: 9.867

5.  Expression cloning of oncogenes by retroviral transfer of cDNA libraries.

Authors:  I Whitehead; H Kirk; R Kay
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

6.  Molecular cloning of a human cannabinoid receptor which is also expressed in testis.

Authors:  C M Gérard; C Mollereau; G Vassart; M Parmentier
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

7.  An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing.

Authors:  D Shire; C Carillon; M Kaghad; B Calandra; M Rinaldi-Carmona; G Le Fur; D Caput; P Ferrara
Journal:  J Biol Chem       Date:  1995-02-24       Impact factor: 5.157

8.  Evi-5, a common site of retroviral integration in AKXD T-cell lymphomas, maps near Gfi-1 on mouse chromosome 5.

Authors:  X Liao; A M Buchberg; N A Jenkins; N G Copeland
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Enhanced growth of Legionella pneumophila in tetrahydrocannabinol-treated macrophages.

Authors:  S Arata; C Newton; T Klein; H Friedman
Journal:  Proc Soc Exp Biol Med       Date:  1992-01

10.  Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias.

Authors:  T Nakamura; D A Largaespada; J D Shaughnessy; N A Jenkins; N G Copeland
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

View more
  8 in total

Review 1.  Pharmacological characterization of GPR55, a putative cannabinoid receptor.

Authors:  Haleli Sharir; Mary E Abood
Journal:  Pharmacol Ther       Date:  2010-03-16       Impact factor: 12.310

Review 2.  Cannabinoid receptors: nomenclature and pharmacological principles.

Authors:  Linda Console-Bram; Jahan Marcu; Mary E Abood
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-28       Impact factor: 5.067

Review 3.  CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity.

Authors:  Emmanuel S Onaivi; Hiroki Ishiguro; Shanzhi Gu; Qing-Rong Liu
Journal:  J Psychopharmacol       Date:  2011-03-29       Impact factor: 4.153

Review 4.  CB1 and CB2 Receptor Pharmacology.

Authors:  Allyn C Howlett; Mary E Abood
Journal:  Adv Pharmacol       Date:  2017-06-12

Review 5.  Cannabinoids and cancer: pros and cons of an antitumour strategy.

Authors:  Maurizio Bifulco; Chiara Laezza; Simona Pisanti; Patrizia Gazzerro
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

6.  Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincide with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2.

Authors:  P J Valk; Y Vankan; M Joosten; N A Jenkins; N G Copeland; B Löwenberg; R Delwel
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  The common viral insertion site Evi12 is located in the 5'-noncoding region of Gnn, a novel gene with enhanced expression in two subclasses of human acute myeloid leukemia.

Authors:  Eric van den Akker; Yolanda Vankan-Berkhoudt; Peter J M Valk; Bob Löwenberg; Ruud Delwel
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Retroviral insertions in the VISION database identify molecular pathways in mouse lymphoid leukemia and lymphoma.

Authors:  Keith C Weiser; Bin Liu; Gwenn M Hansen; Darlene Skapura; Kathryn E Hentges; Sujatha Yarlagadda; Herbert C Morse Iii; Monica J Justice
Journal:  Mamm Genome       Date:  2007-10-10       Impact factor: 2.957

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.